[Experimental rationale for the optimization of chemotherapy for alveococciasis].
Chernikova
E A
EA
Legon'kov
Iu A
IuA
Kovalenko
F P
FP
D000284:Administration, Oral; D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000969:Antinematodal Agents / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004443:Echinococcosis / Q000188:drug therapy*; D004446:Echinococcus; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use*; D051381:Rats
D000871:Anthelmintics; D000969:Antinematodal Agents; D008463:Mebendazole; D015766:Albendazole